SIGA Technologies Inc (SIGA) Stock Analysis

SIGA Technologies Inc (SIGA) is a publicly traded company in the HEALTHCARE sector. It trades at $4.32, carries a market capitalization of $318.45M, a price-to-earnings ratio of 15.86. This page summarizes the public market data, fundamentals, and frequently asked questions for SIGA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

SIGA Technologies Inc currently has a Neutral sentiment score of -0.01.

About SIGA Technologies Inc

SIGA Technologies, Inc. is a New York-based commercial-stage pharmaceutical company committed to developing and commercializing innovative therapeutics for infectious diseases, with a primary focus on its flagship treatment, TPOXX, which effectively addresses smallpox. Through its robust biodefense initiatives and strategic collaborations with government agencies, SIGA significantly contributes to enhancing public health safety and preparedness against biothreats. The company is well-position...

GNG Research Analysis

GNG Research scores SIGA Technologies Inc (SIGA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SIGA.

Frequently Asked Questions

Does SIGA pay dividends?

SIGA Technologies Inc (SIGA) does not currently pay a regular dividend.

What is SIGA's P/E ratio?

SIGA Technologies Inc has a price-to-earnings (P/E) ratio of 15.86.

What is SIGA's market cap?

SIGA Technologies Inc (SIGA) has a market capitalization of $318.45M with a current stock price of $4.32.